Coming Soon Announcement
We are excited to announce our new CU Medicine brand and website!
The website you are on currently, will redirect to the new CU Medicine website starting Tuesday, January 19, 2020.
Our new website is designed to be the central hub of resources where visitors can find a wealth of information about CU Medicine providers, clinic locations and much more.
Steven Ahrendt, MD
Professor, Surgery-Surgical Oncology
Director, Cytoreductive Surgery/HIPEC Program
Conditions & Treatments
Surgery, Board Certification
Advanced Specialty Training in Surgical Oncology, Certificate
Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
Clinical Interest for Patients
My clinical interests include the treatment of patients with abdominal cancer including the care of patients with appendiceal, colon, and ovarian cancer, malignant mesothelioma, pseudomyxoma peritonei, and other abdominal malignancies with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
My goal is to provide personalized compassionate surgical care to every patient. I also strive to guide and support my patients through their multidisciplinary cancer treatment and survivorship.